ZNTL(Zentalis Pharmaceuticals, Inc.) · 财务报表

ZNTL(Zentalis Pharmaceuticals, Inc.) 的财务报表:医疗保健,生物技术。数据来自 SEC 公开申报与市场行情,不构成投资建议。

近年年度财务(SEC XBRL)
科目FY 截至 2022-12-31FY 截至 2023-12-31FY 截至 2024-12-31FY 截至 2025-12-31
营业收入$0$0$67.42M$0
毛利润————
营业利润−$227.29M−$299.51M−$191.19M−$152.81M
净利润−$236.81M−$292.19M−$165.84M−$137.06M
经营现金流−$163.75M−$207.82M−$170.86M−$125.25M
自由现金流−$166.30M−$208.41M−$171.08M−$125.25M
摊薄每股收益$-4.48$-4.47$-2.33$-1.91

Zentalis Pharmaceuticals, Inc. ZNTL